Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2025

Jan 14, 2025

33018_dirs_2025-01-14_ab5d0e64-b358-4e0a-84ac-339946c5dd50.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2024-12-26

Reporting Person: Kuhn Thomas R. (Director, Chairman)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-12-26 Stock Option (Right to Buy) $31.25 A 7108 Acquired 2034-12-26 Common Stock (7108) Direct

Footnotes

F1: This amended Form 4 is being filed to correct the previously reported grant amount of 61,804 option shares to the Reporting Person to reflect an actual grant of 7,108 option shares. The previously reported amount exceeded the compensation limit for non-employee directors set forth in the Issuer's 2023 Stock Plan by 54,696 option shares (the "Excess Option Shares"). The grant of the Excess Option Shares was null and void and has been rescinded by the Issuer.

F2: The option shares vest in full on December 26, 2027, subject to the Reporting Person's continued service with the Issuer through this date.